March 2017


In this Issue


Progress in Perspective




EVAR: Progress in Perspective

By Robert Y. Rhee, MD, and Hence J.M. Verhagen, MD, PhD


True Long-Term Results: What Have We Learned?

A discussion of updated long-term data from randomized studies and their implication on the approach to endovascular aneurysm repair.

By Theodorus G. van Schaik, MD; Kak K. Yeung, MD, PhD; Hence J.M. Verhagen, MD, PhD; and Jan D. Blankensteijn, MD, PhD

Ask the Experts: What Have You Learned From Long-Term Data Sets Beyond 10 Years, and How Will These Data Affect Your Practice?

Experts discuss key lessons from long-term EVAR studies and what they mean for the future.

With Sean P. Lyden, MD, FACS; Ian M. Loftus, MD, FRCS; Vincent Riambau, MD, PhD; Ramesh K. Tripathi, MD, FICS, FRCS, FACP, FRACS Vascular; and Mark A. Farber, MD

Today’s Borderline EVAR Candidates

A look at the patient characteristics and anatomic variations not represented in current guidelines and the best evidence for treatment.

By Jacob Budtz-Lilly, MD; Anders Wanhainen, MD, PhD; and Kevin Mani, MD, PhD, FEBVS

Type II Endoleaks: Will They Ever Be Conquered?

A review of type II endoleak natural history, frequency in procedures, imaging modalities, and current treatment options.

By Sharif H. Ellozy, MD

Benefits of Immediate Cone-Beam CT After EVAR

Assessing technical success after standard and fenestrated EVAR.

With Robert Y. Rhee, MD

Post-EVAR Surveillance Considerations

Evaluating and stratifying risks based on currently available data.

By Frederico Bastos Gonçalves, MD, PhD

Post-EVAR Surveillance: Perspectives on the Role of Duplex Ultrasound and Long-Term Monitoring

Dr. Rabih Chaer describes the benefits and limitations of duplex ultrasound, protocols in standard- and high-risk patients, and tips for obtaining optimal ultrasound results.

With Rabih A. Chaer, MD

EVAR 2020: Training Future Aortic Specialists

Emerging needs and the role of simulation.

By David Pakeliani, MD; Isabelle Van Herzeele, MD, PhD; Mario L. Lachat, MD; and Frank E.G. Vermassen, MD, PhD

Ask the Experts: Is 16 F Small Enough? Will < 16 F Be Durable?

Experts discuss the impact of low-profile devices and the challenges to further reducing profile size.

With Michael D. Dake, MD; Jonathan S. Deitch, MD, FACS; Eric L.G. Verhoeven, MD, PhD; and Edward Y. Woo, MD


The Joint Venous Consortium: Rationale and Proposed Goals

Maximizing the doctor/patient relationship through education and oversight.

By Jose I. Almeida, MD, FACS; Steve Elias, MD, FACS; and Neil M. Khilnani, MD

Expert Opinions on Hot Topics in Endovenous Therapy

Following the recent 2017 American Venous Forum meeting, we asked key opinion leaders from the United States and abroad their thoughts on some of the most discussed issues that continue to be debated.

With Sergio Gianesini, MD; Ian Franklin, MBBS, MS, FRCS(Gen Surg); Evgeny Shaydakov, MD, PhD; and Patrick E. Muck, MD


Sponsored by Philips Volcano

Office-Based Lab Models: Getting Started

With Donald S. Cross, MD, FACC; Alberto Gonzalez, MD, FACS; and Kenneth J. Wright, MD, FACS


Sponsored by Medtronic

A Proposal for Standardizing Restenosis Patterns of Femoropopliteal Artery Disease

By Lawrence A. Garcia, MD


Sponsored by Cordis Corporation

Ultra-Low-Profile in Practice

Discussing performance, durability, and the latest data for the INCRAFT® AAA stent graft.

By Giovanni Torsello, MD


Sponsored by Lombard Medical, Inc.

Evolution Not Revolution: The Altura Stent Graft

Taking EVAR to new heights.

By Paul Hayes, MD


An Interview With Ripal T. Gandhi, MD, FSVM

Dr. Gandhi discusses his current research efforts in peripheral artery disease, venous disease, and interventional oncology and offers his best advice for radiation safety practices.


Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.